[
    [
        {
            "time": "2019-06-01",
            "original_text": "「药你来说」6家中药老字号悉数调降制药业务 云南白药变身成日化企业？",
            "features": {
                "keywords": [
                    "中药老字号",
                    "调降制药业务",
                    "云南白药",
                    "日化企业"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "中药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "「药你来说」6家中药老字号悉数调降制药业务 云南白药变身成日化企业？",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "2019-06-01",
            "original_text": "医药行业政策点评:医改任务清单落地,改革进入深水区",
            "features": {
                "keywords": [
                    "医药行业",
                    "政策",
                    "医改",
                    "改革"
                ],
                "sentiment_score": 0.5,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药行业政策点评:医改任务清单落地,改革进入深水区",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 4,
                "Market_Scope": 10,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-06-01",
            "original_text": "2019年6月医药行业投资策略:行业数据逐渐回暖,政策推动结构分化",
            "features": {
                "keywords": [
                    "医药行业",
                    "投资策略",
                    "行业数据",
                    "政策",
                    "结构分化"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "2019年6月医药行业投资策略:行业数据逐渐回暖,政策推动结构分化",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 4,
                "Headline_Structure": 6,
                "Source_Recency": 3
            }
        }
    ]
]